Literature DB >> 9343200

Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.

S Weger1, A Wistuba, D Grimm, J A Kleinschmidt.   

Abstract

Adeno-associated virus type 2 (AAV-2) gene expression is tightly controlled by functions of the helper virus as well as by the products of its own viral rep gene. Double-immunofluorescence studies of Rep and VP protein expression in cells coinfected with AAV-2 and adenovirus type 2 showed that a large proportion of these cells expressed Rep78 and Rep52 but no capsid proteins. The percentage of Rep78/Rep52- and capsid protein-positive cells was strongly influenced by the relative ratio of AAV-2 to adenovirus type 2. In contrast, nearly all cells positive for Rep68/Rep40 were also positive for capsid protein expression. Examination of p40 promoter transactivation by individual Rep proteins in the presence of adenovirus, however, showed that both Rep78 and Rep68 efficiently stimulated p40 mRNA accumulation and capsid protein expression. This strong transactivation was reliant upon the presence of terminal repeats and correlated with template amplification. In replication-deficient expression constructs, transactivation was observed only with Rep68 and was dependent on the linear Rep binding site within the left terminal repeat which was detected in the presence of high adenovirus concentrations. In the absence of any terminal repeat sequences, Rep68 expression again led to a minor transactivation of capsid protein expression which was detectable only at low adenovirus concentrations. This low level of transactivation of capsid protein expression by Rep proteins in the absence of terminal repeats resulted in a lower efficiency of capsid assembly. The data show a dominant influence of adenovirus type 2 functions on AAV-2 gene expression, a requirement for terminal repeats for strong transactivation of the p40 promoter by Rep proteins, and differential influences of Rep78 and Rep68 on AAV-2 promoters. Implications for the production of recombinant AAV-2 vectors are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343200      PMCID: PMC192306     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA.

Authors:  C A Chen; H Okayama
Journal:  Biotechniques       Date:  1988 Jul-Aug       Impact factor: 1.993

2.  Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Efficient transactivation of the minute virus of mice P38 promoter requires upstream binding of NS1.

Authors:  C Lorson; L R Burger; M Mouw; D J Pintel
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

Authors:  S R Kyöstiö; R S Wonderling; R A Owens
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.

Authors:  D M McCarty; D J Pereira; I Zolotukhin; X Zhou; J H Ryan; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression.

Authors:  B J Thomson; F W Weindler; D Gray; V Schwaab; R Heilbronn
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

7.  Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels.

Authors:  S R Kyöstiö; R A Owens; M D Weitzman; B A Antoni; N Chejanovsky; B J Carter
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Mutational analysis of the adeno-associated virus rep gene.

Authors:  Q Yang; A Kadam; J P Trempe
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins.

Authors:  A Wistuba; S Weger; A Kern; J A Kleinschmidt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters.

Authors:  M Hörer; S Weger; K Butz; F Hoppe-Seyler; C Geisen; J A Kleinschmidt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  26 in total

1.  Adeno-associated virus RNAs appear in a temporal order and their splicing is stimulated during coinfection with adenovirus.

Authors:  M B Mouw; D J Pintel
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Establishment of a High-Yield Recombinant Adeno-Associated Virus/Human Bocavirus Vector Production System Independent of Bocavirus Nonstructural Proteins.

Authors:  Ziying Yan; Wei Zou; Zehua Feng; Weiran Shen; Soo Yeun Park; Xuefeng Deng; Jianming Qiu; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2019-01-31       Impact factor: 5.695

3.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging.

Authors:  Svenja Bleker; Michael Pawlita; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

6.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6).

Authors:  Qing Xie; Thomas F Lerch; Nancy L Meyer; Michael S Chapman
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

8.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4.

Authors:  S Weger; M Wendland; J A Kleinschmidt; R Heilbronn
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein.

Authors:  Daniel F Lackner; Nicholas Muzyczka
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.